新型冠状病毒肺炎患者经鼻高流量氧疗使用管理专家共识_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

倪忠 ¹ ^* , 秦浩 ² ^* , 李洁 ³ ^* , 王启星 ⁴ , 王俊 ² , 景国强 ⁵ , 徐亮 ⁶ , 代冰 ⁷ , 王胜昱 ⁸ , 葛慧青 ⁹ , 夏金根 ¹⁰ , 刘凯 ¹¹ , 何国军 ¹² , 陈荣璋 ¹³ , 方毅敏 ¹⁴ , 梁宗安 ¹ , 陈荣昌 ¹⁵ ,  张伟 ² ,  罗凤鸣；中华医学会呼吸病学分会呼吸治疗学组

1. ;
2. ;
3. ;
4. ;
5. ;
6. ;
7. ;
8. ;
9. ;
10. ;
11. ;
12. ;
13. ;
14. ;
15. ;

Corresponding author：

张伟, Email: zhangweismmu@126.com; 罗凤鸣；中华医学会呼吸病学分会呼吸治疗学组, Email: luofengming@hotmail.com

Keywords：

DOI：

10.7507/1671-6205.202002031

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 倪忠, 秦浩, 李洁, 王启星, 王俊, 景国强, 徐亮, 代冰, 王胜昱, 葛慧青, 夏金根, 刘凯, 何国军, 陈荣璋, 方毅敏, 梁宗安, 陈荣昌, 张伟, 罗凤鸣；中华医学会呼吸病学分会呼吸治疗学组. 新型冠状病毒肺炎患者经鼻高流量氧疗使用管理专家共识. Chinese Journal of Respiratory and Critical Care Medicine, 2020, 19(2): 110-115. doi: 10.7507/1671-6205.202002031 Copy

1.	国家卫生健康委办公厅国家中医药管理局办公室《新型冠状病毒感染的肺炎诊疗方案 (试行第五版)》[EB/OL].http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
2.	中华医学会呼吸病学分会呼吸危重症医学学组中国医师协会呼吸医师分会危重症医学工作委员会. 成人经鼻高流量湿化氧疗临床规范应用专家共识. 中华结核与呼吸杂志, 2019, 42(2): 83-91.
3.	罗裕锋, 瞿嵘, 凌云, 等. 中国首例输入性中东呼吸综合征患者经鼻高流量氧疗的效果观察. 中华危重病急救医学, 2015, 27(10): 841-844.
4.	Roca O, Caralt B, MessikaJ, et al. an index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med, 2019, 199(11): 1368-1376.
5.	Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
6.	WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf.
7.	Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J, 2019, 53(4): pii1802339.
8.	Kang BJ, Koh Y, Lim CM, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med, 2015, 41(4): 623-632.
9.	Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med, 2019, 45(5): 563-572.
10.	Rello J, Pérez M, Roca O, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care, 2012, 27(5): 434-439.
11.	Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015, 372(23): 2185-2196.
12.	Guitton C, Ehrmann S, Volteau C, et al. Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med, 2019, 45(4): 447-458.
13.	Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
14.	Weber DJ, Rutala WA. Nosocomial infections associated with respiratory therapy. InHospital Epidemiology and Infection Control 3rd edition. Edited by: Mayhall CG. Baltimore: Williams & Wilkins, 1996, 748-758.
15.	Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069.
16.	Ding L, Wang L, Ma W, et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care, 2020, 24(1): 28.
17.	Pisani L, Astuto M, Prediletto I, et al. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology, 2019, 25(6): 348-354.
18.	Norkienė I, d'Espiney R, Martin-Lazaro JF. Effectiveness of high-flow nasal oxygen therapy in management of acute hypoxemic and hypercapnic respiratory failure. Acta Med Litu, 2019, 26(1): 46-50.
19.	Nishimura M. High-flow nasal cannula oxygen therapy devices. Respir Care, 2019, 64(6): 735-742.
20.	García-de-Acilu M, Patel BK, Roca O, et al. Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?. Curr Opin Crit Care, 2019, 25(1): 54-62.
21.	Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care, 2018, 22(1): 180.
22.	Koyauchi T, Hasegawa H, Kanata K, et al. Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders: a retrospective single-center study. Respiration, 2018, 96(4): 323-329.
23.	Kim ES, Lee H, Kim SJ, et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis, 2018, 10(2): 882-888.
24.	Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J, 2018, 12(6): 2046-2056.

1. 国家卫生健康委办公厅国家中医药管理局办公室《新型冠状病毒感染的肺炎诊疗方案 (试行第五版)》[EB/OL].http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml.
2. 中华医学会呼吸病学分会呼吸危重症医学学组中国医师协会呼吸医师分会危重症医学工作委员会. 成人经鼻高流量湿化氧疗临床规范应用专家共识. 中华结核与呼吸杂志, 2019, 42(2): 83-91.
3. 罗裕锋, 瞿嵘, 凌云, 等. 中国首例输入性中东呼吸综合征患者经鼻高流量氧疗的效果观察. 中华危重病急救医学, 2015, 27(10): 841-844.
4. Roca O, Caralt B, MessikaJ, et al. an index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med, 2019, 199(11): 1368-1376.
5. Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf.
7. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J, 2019, 53(4): pii1802339.
8. Kang BJ, Koh Y, Lim CM, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med, 2015, 41(4): 623-632.
9. Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med, 2019, 45(5): 563-572.
10. Rello J, Pérez M, Roca O, et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care, 2012, 27(5): 434-439.
11. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015, 372(23): 2185-2196.
12. Guitton C, Ehrmann S, Volteau C, et al. Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient: a randomized clinical trial. Intensive Care Med, 2019, 45(4): 447-458.
13. Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med, 2017, 195(9): 1207-1215.
14. Weber DJ, Rutala WA. Nosocomial infections associated with respiratory therapy. InHospital Epidemiology and Infection Control 3rd edition. Edited by: Mayhall CG. Baltimore: Williams & Wilkins, 1996, 748-758.
15. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, 323(11): 1061-1069.
16. Ding L, Wang L, Ma W, et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care, 2020, 24(1): 28.
17. Pisani L, Astuto M, Prediletto I, et al. High flow through nasal cannula in exacerbated COPD patients: a systematic review. Pulmonology, 2019, 25(6): 348-354.
18. Norkienė I, d'Espiney R, Martin-Lazaro JF. Effectiveness of high-flow nasal oxygen therapy in management of acute hypoxemic and hypercapnic respiratory failure. Acta Med Litu, 2019, 26(1): 46-50.
19. Nishimura M. High-flow nasal cannula oxygen therapy devices. Respir Care, 2019, 64(6): 735-742.
20. García-de-Acilu M, Patel BK, Roca O, et al. Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?. Curr Opin Crit Care, 2019, 25(1): 54-62.
21. Di Mussi R, Spadaro S, Stripoli T, et al. High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care, 2018, 22(1): 180.
22. Koyauchi T, Hasegawa H, Kanata K, et al. Efficacy and tolerability of high-flow nasal cannula oxygen therapy for hypoxemic respiratory failure in patients with interstitial lung disease with do-not-intubate orders: a retrospective single-center study. Respiration, 2018, 96(4): 323-329.
23. Kim ES, Lee H, Kim SJ, et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis, 2018, 10(2): 882-888.
24. Lee MK, Choi J, Park B, et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. Clin Respir J, 2018, 12(6): 2046-2056.

Previous Article
新型冠状病毒肺炎患者全病程管控关键技术集成与优化应用
Next Article
新型冠状病毒肺炎患者呼吸机使用感控管理专家共识

Chinese Journal of Respiratory and Critical Care Medicine

新型冠状病毒肺炎患者经鼻高流量氧疗使用管理专家共识

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content